Search
Cardiolipin Biosynthesis CL(a-13:0/i-24:0/a-15:0/a-17:0)[rac]
smpdb.ca/view/SMP0493247MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … All membrane-localized enzymes are coloured dark green in the image.
Cardiolipin Biosynthesis CL(a-13:0/i-24:0/a-17:0/a-21:0)[rac]
smpdb.ca/view/SMP0493355MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … All membrane-localized enzymes are coloured dark green in the image.
Cardiolipin Biosynthesis CL(a-13:0/i-24:0/a-21:0/a-17:0)[rac]
smpdb.ca/view/SMP0493446MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … All membrane-localized enzymes are coloured dark green in the image.
Cardiolipin Biosynthesis CL(a-13:0/i-24:0/a-25:0/a-13:0)[rac]
smpdb.ca/view/SMP0493544MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … All membrane-localized enzymes are coloured dark green in the image.
Cobimetinib
go.drugbank.com/drugs/DB05239ApprovedInvestigationalCobimetinib is an orally active, potent and highly selective small molecule inhibiting mitogen-activated protein kinase kinase 1 (MAP2K1 or MEK1), and central components of the RAS/RAF/MEK/ERK signal transduction … It has been approved in Switzerland and the US, in combination with vemurafenib for the treatment of patients with unresectable or metastatic BRAF V600 mutation-positive melanoma.
Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic IndexProducts: COTELLIC® (COBIMETINIB) 20 MG TABLETAS RECUBIERTASAfatinib
go.drugbank.com/drugs/DB08916ApprovedInvestigationalAfatinib is a 4-anilinoquinazoline tyrosine kinase inhibitor in the form of a dimaleate salt available as Boehringer Ingelheim's brand name Gilotrif [FDA Label]. … For oral use, afatinib tablets are a first-line (initial) treatment for patients with metastatic non-small cell lung cancer (NSCLC) with common epidermal growth factor receptor (EGFR) mutations as detected
Categories: P-glycoprotein inhibitors, P-glycoprotein substratesProducts: GIOTRIF® 30 MG, GIOTRIF® 40 MGCardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-13:0/a-13:0)[rac]
smpdb.ca/view/SMP0351511MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … All membrane-localized enzymes are coloured dark green in the image.
Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-13:0/a-25:0)[rac]
smpdb.ca/view/SMP0351552MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … All membrane-localized enzymes are coloured dark green in the image.
Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-15:0/a-21:0)[rac]
smpdb.ca/view/SMP0351649MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … All membrane-localized enzymes are coloured dark green in the image.
Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-15:0/a-25:0)[rac]
smpdb.ca/view/SMP0351652MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … All membrane-localized enzymes are coloured dark green in the image.